Large Cap Biopharma Performance And Metrics Q3 2020; ETFs Are Winners

COMPANY Ticker Price 2017 Price Price MktCap

% Perform

         
    1/15/18 Rev$B 11/21/20 11/1/19 2020 YTD   FWD Analyst %  
      2018 $   $B   P/S PE Recom Div  
Abbvie ABBV 100.340 27.27 100.84 81.75 176 13.89 4.33 8.28 2 5.16  
Alexion ALXN 122.710 3.47 121.38 109.38 26.7 12.23 4.56 9.38 2.2    
Amgen AMGN 185.040 23 223.17 217.95 130.8 -7.43 5.23 13.12 2.4 2.87  
AstraZeneca AZN     55.3 46.88 141.5 10.91 5.47 21.9 1.6 2.53  
Biogen BIIB 335.950 11.84 244.15 299.2 37.55 -17.72 2.63 9.6 2.7    
Bristol Myers BMY 62.810 19.92 61.61 57.16 140.3 -4 3.56 8.26 1.9 2.9  
Celgene* (BMY) CELG 106.000 12.5 n/a 108.53 77 n/a 4.69 8.7 n/a    
                         
Gilead Sci GILD 79.020 27.48 60.11 64.66 76 -7.49 3.28 9.03 2.5 4.53  
GlaxoSmithK GSK     37.03 45 92.87 (21,20) 2.04 12.05 2 5.48  
Merck MRK 58.660 39.8 80.45 84.94 203.4 -11.54 4.3 12.64 2 3.23  
Regeneron REGN 366.960 5.52 517.74 310.48 54.9 38.15 6.66 14.22 2.1    
Vertex VRTX 158.000 2.3 266.5 215.21 55.12 -1.71 9.2 18.74 2    
                         
XBI       126.04 83.66   32.52          
IBB       138.87 109.85   15.24       0.23  
FBT       158.1 132.92   6.31          
FBIOX       26.24 20.26   25.5          
XLV       108 94.87   6.81          
XPH       48.15 39.47   5.43          
QQQ       290.38     36.58          
                       
1 2
View single page >> |

Disclosure: Long ABBV, AZN, BMY, FBIOX, GILD, MRK, XBI

None.

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.